ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
271.94
-5.50 (-1.98%)
At close: Jul 31, 2025, 4:00 PM
270.00
-1.94 (-0.71%)
Pre-market: Aug 1, 2025, 7:49 AM EDT
bluebird bio Revenue
In the fiscal year ending June 30, 2025, ResMed had annual revenue of $5.15B with 9.84% growth. ResMed had revenue of $1.35B in the quarter ending June 30, 2025, with 10.20% growth.
Revenue (ttm)
$5.15B
Revenue Growth
+9.84%
P/S Ratio
7.75
Revenue / Employee
$515,664
Employees
9,980
Market Cap
39.81B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2025 | 5.15B | 461.03M | 9.84% |
Jun 30, 2024 | 4.69B | 462.30M | 10.95% |
Jun 30, 2023 | 4.22B | 644.87M | 18.02% |
Jun 30, 2022 | 3.58B | 381.30M | 11.93% |
Jun 30, 2021 | 3.20B | 239.81M | 8.11% |
Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
RMD News
- 10 hours ago - ResMed Inc. (RMD) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 15 hours ago - Resmed beats quarterly profit estimates on strong demand for sleep devices - Reuters
- 16 hours ago - Resmed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2025 - GlobeNewsWire
- 2 days ago - Spot Outliers Like ResMed Early with Money Flows - FXEmpire
- 4 weeks ago - Top 15 High-Growth Dividend Stocks For July 2025 - Seeking Alpha
- 4 weeks ago - Resmed to Report Fourth Quarter Fiscal 2025 Earnings on July 31, 2025 - GlobeNewsWire
- 7 weeks ago - ResMed: A Sleeping Giant Hiding In Plain Sight - Seeking Alpha
- 2 months ago - Top 15 High-Growth Dividend Stocks For June 2025 - Seeking Alpha